Securian Asset Management Inc. Sells 530 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Securian Asset Management Inc. reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,748 shares of the company’s stock after selling 530 shares during the quarter. Securian Asset Management Inc.’s holdings in HCA Healthcare were worth $2,926,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the 4th quarter worth $31,000. Legacy Investment Solutions LLC bought a new position in HCA Healthcare in the 3rd quarter worth $39,000. Activest Wealth Management raised its holdings in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. raised its holdings in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Finally, Eastern Bank bought a new position in HCA Healthcare in the 4th quarter worth $62,000. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HCA shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Truist Financial reduced their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. Morgan Stanley reduced their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $313.49 on Thursday. The firm’s 50-day moving average price is $318.19 and its 200-day moving average price is $346.27. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a market cap of $77.18 billion, a PE ratio of 14.27, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm posted $5.90 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.92%. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.